Market Cap 291.66M
Revenue (ttm) 405.47M
Net Income (ttm) 53.66M
EPS (ttm) N/A
PE Ratio 20.55
Forward PE N/A
Profit Margin 13.23%
Debt to Equity Ratio 0.00
Volume 706,800
Avg Vol 889,282
Day's Range N/A - N/A
Shares Out 74.59M
Stochastic %K 54%
Beta 0.05
Analysts Sell
Price Target $5.75

Latest News on OSUR

OraSure to Present at the J.P Morgan Healthcare Conference

Jan 7, 2025, 4:05 PM EST - 22 days ago

OraSure to Present at the J.P Morgan Healthcare Conference


OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Jan 7, 2025, 7:05 AM EST - 22 days ago

OraQuick® HIV Self-Test Now Approved for Use in Adolescents


OraSure Technologies Acquires Sherlock Biosciences

Dec 19, 2024, 4:02 PM EST - 5 weeks ago

OraSure Technologies Acquires Sherlock Biosciences


OraSure to Participate in Upcoming Investor Conference

Nov 18, 2024, 4:05 PM EST - 2 months ago

OraSure to Participate in Upcoming Investor Conference


OraSure Reports Q3 '24 Revenue of $39.9 Million

Nov 6, 2024, 4:05 PM EST - 3 months ago

OraSure Reports Q3 '24 Revenue of $39.9 Million


OraSure: An NCAV Diamond In The COVID Rough

Nov 4, 2024, 9:32 AM EST - 3 months ago

OraSure: An NCAV Diamond In The COVID Rough


OraSure Technologies Supports National HIV Testing Day

Jun 27, 2024, 7:05 AM EDT - 7 months ago

OraSure Technologies Supports National HIV Testing Day


OraSure Reports Q4 ‘23 Revenue of $75.9 Million

Feb 27, 2024, 4:05 PM EST - 1 year ago

OraSure Reports Q4 ‘23 Revenue of $75.9 Million


OraSure to Participate in Upcoming Investor Conferences

Nov 13, 2023, 4:15 PM EST - 1 year ago

OraSure to Participate in Upcoming Investor Conferences


OraSure: Valuation Upside On The Table At 16x Forward P/E

May 17, 2023, 5:47 AM EDT - 1 year ago

OraSure: Valuation Upside On The Table At 16x Forward P/E


OraSure Technologies: As Good As It Gets

May 15, 2023, 5:57 PM EDT - 1 year ago

OraSure Technologies: As Good As It Gets


March Madness: My Final 4 Small Cap Stocks Under $10

Mar 13, 2023, 6:00 AM EDT - 2 years ago

March Madness: My Final 4 Small Cap Stocks Under $10

IMMR PAYO


OraSure: Revising To Buy Following Extensive Growth Route

Feb 28, 2023, 10:47 AM EST - 2 years ago

OraSure: Revising To Buy Following Extensive Growth Route


OraSure: Concentration Risk From Covid Revenue, Reaffirm Hold

Nov 30, 2022, 7:12 PM EST - 2 years ago

OraSure: Concentration Risk From Covid Revenue, Reaffirm Hold